1 active not recruiting, 1 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 1, Completed 1 |
Follow Bacillus Calmette Guerin: new trials by email Literature Review of Bacillus Calmette Guerin trials Research Report on Bacillus Calmette Guerin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Intravesical B.C.G and Gemcitabine on Semen Analysis and Testicular Volume in NMIBC Bacillus Calmette Guerin, Gemcitabine HCL (Gemzar) - Urothelial Carcinoma Bladder, Sperm Count, Low | Phase 4 | Completed | Assiut University | 86 | 2023-04-01 | 2026-10-29 |
| NORTH-REG Dwell-Time Study Bacillus Calmette Guerin - Side Effect of Drug | Phase 4 | Active not recruiting | Jørgen Bjerggaard Jensen | 314 | 2021-02-03 | 2026-03-03 |
Fibrosis (1) · Non-Muscle Invasive Bladder Neoplasms (1) · Oligospermia (1)
Assiut University (1) · Jørgen Bjerggaard Jensen (1)
Denmark (1) · Egypt (1) · Iceland (1) · Sweden (1)
Ahmed M Eltaher, professor (1) · Hosny A Behnsawy, associate professor (1) · Mohammed H Zarzour, lecturer (1)